F. Martin

Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective.

M. Knip, W. Hagopian, A. Ziegler, 2022, Diabetes.

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

E. Bonifacio, M. Knip, D. Dunger, 2022, Trials.

Childhood Height Growth Rate Association With the Risk of Islet Autoimmunity and Development of Type 1 Diabetes

J. Toppari, Kenney Ng, Kathleen C. Waugh, 2022, The Journal of clinical endocrinology and metabolism.

Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children

W. Hagopian, J. Toppari, Kenney Ng, 2022, Diabetologia.

Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes until young adulthood: a prospective cohort study.

W. Hagopian, J. Toppari, A. Ziegler, 2023, The Lancet. Child & adolescent health.

Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children.

W. Hagopian, J. Toppari, Kenney Ng, 2021, Diabetes care.

Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes

W. Hagopian, J. Toppari, Kenney Ng, 2022, Diabetes.

Gene expression signature predicts rate of type 1 diabetes progression

Maria K. Jaakkola, E. Bonifacio, C. de Beaufort, 2023, EBioMedicine.

Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies

J. Podichetty, K. Romero, M. Haller, 2023, CPT: pharmacometrics & systems pharmacology.